TSE:5599 stock news
This page provides real-time market news, earnings updates, and company announcements related to S&J Corporation (TSE:5599).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 22:18 JST
J. M. Smucker Shares: Expert Predictions and Evaluations
101 finance2026-02-17 11:48:12
Champion Safe Wraps Successful Participation at Nation's Best Sports Spring Annual Market in Oklahoma City
Finviz2026-02-17 13:33:46
5 Thought-Provoking Analyst Inquiries From Crane NXT’s Fourth Quarter Earnings Call
101 finance2026-02-18 10:00:42
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40
Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer
Finviz2026-02-18 21:09:41
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-18 21:09:42
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Finviz2026-02-19 12:03:42
Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports
101 finance2026-02-19 19:54:42
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
Cipher Mining Stock Before Q4 Earnings: What's in the Offing?
Finviz2026-02-20 18:21:43
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Are financial experts on Wall Street forecasting that Arthur J. Gallagher shares will rise or fall?
101 finance2026-02-20 21:18:41
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
Finviz2026-02-23 14:03:46
Investors Title's Q4 Earnings Slump Y/Y Due to Lower Premium
Finviz2026-02-23 18:42:41
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-24 12:03:58
Is the T. Rowe Price Dividend Growth Fund (PRDGX) Currently a Top Choice Among Mutual Funds?
101 finance2026-02-25 13:06:55
Jacobs Solutions (J) is an Incredible Growth Stock: 3 Reasons Why
Finviz2026-02-25 18:48:45
PEDEVCO Reports Year-End 2025 Proved Reserves
Finviz2026-02-25 21:18:46
YETI’s Fourth Quarter Earnings Call: The Five Key Questions from Analysts
101 finance2026-02-26 10:10:13
Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
Finviz2026-02-26 14:03:09
EMCOR's Q4 Earnings & Revenues Beat Estimates, Operating Margin Up Y/Y
Finviz2026-02-26 16:48:43
Morgan Stanley Raises its Price Target on Edison International (EIX) to $68 from $61
Finviz2026-02-27 03:33:42
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40
Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer
Finviz2026-02-18 21:09:41
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-18 21:09:42
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Finviz2026-02-19 12:03:42
Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports
101 finance2026-02-19 19:54:42
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
Cipher Mining Stock Before Q4 Earnings: What's in the Offing?
Finviz2026-02-20 18:21:43
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Are financial experts on Wall Street forecasting that Arthur J. Gallagher shares will rise or fall?
101 finance2026-02-20 21:18:41
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
Finviz2026-02-23 14:03:46
Investors Title's Q4 Earnings Slump Y/Y Due to Lower Premium
Finviz2026-02-23 18:42:41
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-24 12:03:58
Is the T. Rowe Price Dividend Growth Fund (PRDGX) Currently a Top Choice Among Mutual Funds?
101 finance2026-02-25 13:06:55
Jacobs Solutions (J) is an Incredible Growth Stock: 3 Reasons Why
Finviz2026-02-25 18:48:45
PEDEVCO Reports Year-End 2025 Proved Reserves
Finviz2026-02-25 21:18:46
YETI’s Fourth Quarter Earnings Call: The Five Key Questions from Analysts
101 finance2026-02-26 10:10:13
Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
Finviz2026-02-26 14:03:09
EMCOR's Q4 Earnings & Revenues Beat Estimates, Operating Margin Up Y/Y
Finviz2026-02-26 16:48:43
Morgan Stanley Raises its Price Target on Edison International (EIX) to $68 from $61
Finviz2026-02-27 03:33:42
TSE:5599 stock price change
On the last trading day, TSE:5599 stock closed at 1914.00 JPY, with a price change of -18.90% for the day.
Trade stock perpsTSE:5599 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more